Aerovate Therapeutics : May 2024 Corporate Presentation

Meaningfully Improving the Lives of


Patients with Rare


Cardiopulmonary Disease


Targeting the Hyperproliferative Cause
...

Related Keywords

United States , ,While The Company ,Exchange Commission ,Aerovate Therapeutics Inc ,Forward Looking Statements ,Aerovate Therapeutics ,Securities Litigation Reform Act ,Quarterly Report ,United States Securities ,